Skip to content
Search

Latest Stories

5 summer tips from MHRA for managing medications and devices

5 summer tips from MHRA for managing medications and devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has shared some important summer tips for people taking medicines or using medical devices

People are advised to be mindful of medications that may cause sun reactions, and to watch out for dodgy hay fever treatments and fake weight loss pens.

For those traveling abroad, the MHRA advises considering the suitability of medicines available to reduce the risk of contracting tropical diseases.


Dr Alison Cave, Chief Safety Officer at the MHRA, said: “The summer is an exciting time for many of us, as we take time off to travel and enjoy the warmer weather.

“But it is important to understand what this time of year means for our medicines and medical devices, and take the precautions necessary to use products safely and protect ourselves.”

Watch out for dodgy hay fever treatments

Millions of Britons suffer from hay fever symptoms in the summer. The MHRA advises consulting a healthcare professional to find the best treatment for your symptoms.

People are also warned to be cautious of medicines advertised as hay fever treatments but not approved for use in the UK, such as Kenalog. This is a prescription-only steroid injection licensed as a medicine for other conditions, but not for the treatment of hay fever.

Travelling with an implanted devices

Those who have an implanted electronic medical device – including pacemakers, implanted cardioverter defibrillators (ICDs), neurostimulators, hearing implants, infusion pumps and glucose monitoring devices – are advised to carry their device registration card (also known as implant ID card) to show to airport staff before passing through security.

The MHRA cautioned that some infusion pumps and glucose monitoring devices should not be exposed to screening or scanning systems. People using such devices are strongly recommended to check with the device's manufacturer before traveling.

Diabetics are advised to monitor their glucose carefully on holiday as changes in their routine, climate, and eating habits can affect their condition.

Hand-held screening wands can interfere with implanted devices. The regulator has advised security personnel to keep wands 15cm from the body and pass over devices quickly to avoid delivering inappropriate therapy.

Medicines that can cause sun reactions

The MHRA cautioned that some medicines, like methotrexate, used for inflammatory conditions such as rheumatoid arthritis, psoriasis, Crohn’s disease, and cancer, can cause sun reactions.

Extreme skin sensitivity to UV rays can occur with both low and high doses of treatment. Reactions can include severe sunburn, rashes with papules or blistering, and sometimes swelling. In rare cases, these reactions have contributed to deaths from secondary infections, it said.

Therefore, the MHRA advises individuals taking methotrexate to protect themselves from the sun and UV rays by avoiding sunbeds or tanning equipment, using a high-factor sun protection product, and wearing a hat and clothing that covers their arms and legs.

Check the suitability of medicines for tropical diseases

Traveling abroad may expose you to dangerous diseases like yellow fever and malaria, both spread by mosquitoes in tropical countries. Medicines are available to reduce the risk, but the MHRA stresses the importance of assessing their suitability for each individual.

For example, the MHRA says that the yellow fever vaccine (Stamaril) is highly effective, but it may not be suitable for everyone, as there is a very rare risk of serious side effects.

Due to this, individuals with weakened immunity or those aged 60 and older are advised to consult a healthcare professional about travel precautions. The vaccine may be recommended only if there is a significant risk of yellow fever infection.

Mefloquine (also known as Lariam) can be used to treat or prevent malaria. However, it should not be used by individuals with a history of psychiatric conditions such as depression, anxiety disorders, schizophrenia, or other mental health issues, according to the agency.

Be aware of fake weight loss products

The agency has also warned of criminals selling fake, potentially harmful products online, such as dodgy diet pills or fake weight loss pens.

People are advised to use Ozempic (semaglutide) and Saxenda (liraglutide) pre-filled pens only if they have been prescribed by a qualified healthcare professional.

“If anyone has a concern about their weight and health, you should visit your GP or pharmacist, get a correct diagnosis and if medicines are prescribed, obtain them from a legitimate source,” the MHRA said.

The agency reminded that all pharmacies in Great Britain, including online ones, must be registered with the General Pharmaceutical Council (GPhC) and comply with their standards for registered pharmacies.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less